STOCK TITAN

LifeVantage Declares Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
LifeVantage Corporation (Nasdaq:LFVN) has announced a quarterly cash dividend of $0.035 per share of common stock, to be paid on March 15, 2024, to stockholders of record on March 1, 2024.
Positive
  • None.
Negative
  • None.

The announcement of a quarterly cash dividend by LifeVantage Corporation signifies a distribution of earnings to shareholders, which is typically viewed as a positive signal about a company's financial health and stability. The dividend yield, calculated by dividing the annual dividends per share by the stock's price per share, becomes a key metric for investors seeking income-generating investments. It is essential to assess how this dividend payment aligns with the company's payout ratio, which is the proportion of earnings paid out as dividends to shareholders. A sustainable payout ratio, generally below 75%, indicates that the company can comfortably afford its dividend payments without compromising its growth prospects or operational funds.

Furthermore, the market's reaction to dividend announcements can provide insights into investor sentiment regarding the company's future performance. A steady or increasing dividend can be a sign of confidence from management in the company's profitability and long-term strategy. However, investors should also consider the opportunity cost of dividend payments versus potential reinvestment in the business for growth, as well as the tax implications of dividend income.

LifeVantage Corporation's dividend announcement also serves as an indicator of its competitive positioning within the health and wellness industry. Companies that can afford to pay dividends are often seen as mature and stable, which can be attractive to a certain segment of investors. The decision to pay out dividends might reflect management's understanding of shareholder expectations and the desire to deliver consistent returns, particularly in an industry where consumer trends can rapidly change and affect company revenues.

It is also crucial to analyze the dividend in the context of the company's overall financial strategy, including its capital allocation for research and development, marketing and potential expansion. The health and wellness sector is highly competitive, with continuous innovation and regulatory challenges, so balancing dividend payments with necessary investments is key to maintaining a competitive edge. By examining industry benchmarks and the dividend histories of peer companies, investors can gauge whether LifeVantage's dividend policy is in line with market standards and sustainable in the long run.

SALT LAKE CITY, Jan. 30, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.035 per share of common stock, which will be paid March 15, 2024 to all stockholders of record at the close of business on March 1, 2024.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath & body, and targeted relief products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience® line of skin, hair, bath & body, and targeted relief products. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, Axio® its nootropic energy drink mixes, and PhysIQ, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Cautionary Note Regarding Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, the impact of COVID-19 on our business, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments as a result of future COVID-19 developments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com 


FAQ

What is the ticker symbol for LifeVantage Corporation?

The ticker symbol for LifeVantage Corporation is LFVN.

When will the quarterly cash dividend be paid to stockholders?

The quarterly cash dividend will be paid on March 15, 2024.

How much is the quarterly cash dividend per share of common stock?

The quarterly cash dividend is $0.035 per share of common stock.

When is the record date for the quarterly cash dividend?

The record date for the quarterly cash dividend is March 1, 2024.

Lifevantage Corporation (Delaware)

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Stock Data

79.53M
8.95M
16.35%
28.68%
0.49%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
LEHI

About LFVN

lifevantage is at the forefront of nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. aging is inevitable. and we’re all painfully aware of the toll it takes on our bodies. nutrigenomics is serious science. and it’s graduated from the laboratory to real-life, creating a platform for products that really work – really.